Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
Clinical trial NCT01516307 · COMPLETED
Trial details
- NCT number
- NCT01516307
- Sponsor
- OBI Pharma, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2016-08-01
- Enrollment
- 349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.